A Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome.
clinical practice guidelines
development
neonatal abstinence syndrome
neonatal opioid withdrawal syndrome
prenatal opioid exposure
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
13 Oct 2023
13 Oct 2023
Historique:
received:
05
09
2023
revised:
09
10
2023
accepted:
12
10
2023
medline:
28
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
The prevalence of neonatal abstinence syndrome is increasing, but the number and quality of clinical practice guidelines available are unknown. This systematic review aimed to identify, appraise and evaluate clinical practice guidelines for neonatal abstinence syndrome. A systematic search of databases and the grey literature was conducted between 1 June and 1 July 2022. Full-text guidelines published by national or state-wide institutions were included. The recommendations from each guideline were extracted. The AGREE-II instrument was used to assess guideline quality. Sufficient-quality scores were defined as >60 and good-quality scores were >80 for each domain of AGREE-II. A total of 1703 records were identified, and 22 guidelines from the United States, Australia, Canada and the United Kingdom, published between 2012 to 2021, were included. The quality scores were low, with median scores of 37/100 for stakeholder involvement, 33/100 for methodology, 34/100 for applicability and 0 for editorial independence. Scope and purpose scored 72/100, and presentation scored 85/100. Sixteen (73%) guidelines did not meet the cut-offs for clinical use. Many guidelines were of insufficient quality to guide clinical practice for neonatal abstinence syndrome. This emphasises the need for high-quality studies to inform clinical practice guidelines, improve care and reduce the risk of poor outcomes in these high-risk infants.
Sections du résumé
BACKGROUND
BACKGROUND
The prevalence of neonatal abstinence syndrome is increasing, but the number and quality of clinical practice guidelines available are unknown. This systematic review aimed to identify, appraise and evaluate clinical practice guidelines for neonatal abstinence syndrome.
METHODS
METHODS
A systematic search of databases and the grey literature was conducted between 1 June and 1 July 2022. Full-text guidelines published by national or state-wide institutions were included. The recommendations from each guideline were extracted. The AGREE-II instrument was used to assess guideline quality. Sufficient-quality scores were defined as >60 and good-quality scores were >80 for each domain of AGREE-II.
RESULTS
RESULTS
A total of 1703 records were identified, and 22 guidelines from the United States, Australia, Canada and the United Kingdom, published between 2012 to 2021, were included. The quality scores were low, with median scores of 37/100 for stakeholder involvement, 33/100 for methodology, 34/100 for applicability and 0 for editorial independence. Scope and purpose scored 72/100, and presentation scored 85/100. Sixteen (73%) guidelines did not meet the cut-offs for clinical use.
CONCLUSION
CONCLUSIONS
Many guidelines were of insufficient quality to guide clinical practice for neonatal abstinence syndrome. This emphasises the need for high-quality studies to inform clinical practice guidelines, improve care and reduce the risk of poor outcomes in these high-risk infants.
Identifiants
pubmed: 37892348
pii: children10101685
doi: 10.3390/children10101685
pmc: PMC10605060
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Addict Dis. 1975;2(1-2):141-58
pubmed: 1163358
Hosp Pediatr. 2019 Aug;9(8):585-592
pubmed: 31324654
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
JAMA. 2018 Apr 03;319(13):1362-1374
pubmed: 29614184
Daru. 2019 Jun;27(1):423-431
pubmed: 31093953
JAMA. 2012 May 9;307(18):1934-40
pubmed: 22546608
Paediatr Child Health. 2018 May;23(3):220-226
pubmed: 29769809
Pediatrics. 2002 Apr;109(4):590-3
pubmed: 11927701
Breastfeed Med. 2015 Apr;10(3):135-41
pubmed: 25836677
Obstet Gynecol. 2017 Jul;130(1):10-28
pubmed: 28594753
J Obstet Gynaecol Can. 2017 Oct;39(10):922-937.e2
pubmed: 28935057
N Engl J Med. 2017 Jun 15;376(24):2341-2348
pubmed: 28468518
J Pediatr. 2015 Dec;167(6):1214-20.e3
pubmed: 26364984
Birth. 2018 Dec;45(4):450-458
pubmed: 29411890
Int J Pediatr Otorhinolaryngol. 2021 Feb;141:110504
pubmed: 33229031
N Engl J Med. 2023 Jun 22;388(25):2326-2337
pubmed: 37125831
J Clin Epidemiol. 2019 Apr;108:64-76
pubmed: 30529647
Pediatrics. 2021 Jan;147(1):
pubmed: 33386337
Cochrane Database Syst Rev. 2020 Dec 21;12:CD013217
pubmed: 33348423
BMJ Open. 2017 Jul 31;7(7):e015404
pubmed: 28760789
J Paediatr Child Health. 2020 Dec;56(12):1933-1940
pubmed: 32815631
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Pediatrics. 2020 Nov;146(5):
pubmed: 33106341
Addict Sci Clin Pract. 2014 Sep 09;9(1):19
pubmed: 25199822
Obstet Gynecol. 2017 Aug;130(2):e81-e94
pubmed: 28742676
Brain Res Rev. 2008 Jun;58(1):192-208
pubmed: 18440072
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
PLoS One. 2021 Apr 22;16(4):e0250356
pubmed: 33886670
J Am Med Assoc. 1947 Nov 8;135(10):633
pubmed: 20268632
JAMA Pediatr. 2018 Aug 1;172(8):741-748
pubmed: 29913015
JAMA. 2002 Feb 6;287(5):612-7
pubmed: 11829700
Cochrane Database Syst Rev. 2021 May 18;5:CD002053
pubmed: 34002380
Pediatrics. 2015 Oct;136(4):e811-20
pubmed: 26371197
J Perinatol. 2020 Jul;40(7):1050-1055
pubmed: 32424335
J Popul Ther Clin Pharmacol. 2012;19(3):e488-506
pubmed: 23241498
Pediatrics. 2017 Jun;139(6):
pubmed: 28562267
N Engl J Med. 2015 May 28;372(22):2118-26
pubmed: 25913111
Paediatr Child Health. 2017 Jun;22(3):148-152
pubmed: 29479202
Pediatrics. 2015 Oct;136(4):e803-10
pubmed: 26371196
Pediatrics. 2006 Jun;117(6):e1163-9
pubmed: 16740817
N Engl J Med. 2016 Dec 22;375(25):2468-2479
pubmed: 28002715
J Pediatr. 2001 Mar;138(3):344-8
pubmed: 11241040
BMJ. 1999 Feb 20;318(7182):527-30
pubmed: 10024268
Pediatrics. 2015 May;135(5):842-50
pubmed: 25869370
Front Pharmacol. 2018 Aug 28;9:961
pubmed: 30210343